 |
|
|
|
| |
|
|
|
| |
|
Eighth European Congress For Clinical and Economic Aspacts of Osteoporosis and Osteoarthiritis at Istanbul from 9-12 April 08.Four members from ISBMR will be attending.
|
 |
Join the battle against osteoporosis. Become a
life member of ISBMR and avail numerous benefits .
Download Membership Form 
|
| |
|
Bone Health
Quiz was held at All India Institute of Medical
Sciences in Delhi on 12 October, 2006.
|
|
|
|
 |
|
 |
| >> Bone
Health Quiz to select India's First Bone Master - Preliminary
Stage |
| |
|
 |
September 24, 2006
Bone Health Quiz to select India's First Bone Master
- Preliminary Stage
ISBMR had won the AMGEN Award at Bangkok in 2005 for their
programme Bone Health Quiz. The first two rounds were conducted
at seven Metros across India viz. New Delhi, Mumbai, Kolkata,
Jaipur, Hyderabad, Ahmedabad and Bangalore simultaneously
on 24 September, 2006.The response was very encouraging and
almost 30-40 teams participated in each city. Winners of both
the rounds were suitably awarded.
|
|
| |
| >> First
Annual Conference of The Indian Society for Bone and Mineral Research
|
First Annual Conference
of The Indian Society for Bone and Mineral Research
|
|
| “Symposium
on Metabolic Bone Disorders”, the title of
the first Annual Conference of The Indian Society
for Bone and Mineral Research was held at All India
Institute of Medical Sciences on 10th November 2005.
The symposium was supported and acknowledged by International
Osteoporosis Foundation, Geneva, the leading world known organization,
which is dedicated to fight against osteoporosis. This one-day
event was attended by more than one hundred and fifty delegates,
which included specialists from the field of endocrinology,
gynecology and orthopedics.
The faculty members comprised of endocrine
and osteoporosis specialists from all over India and abroad.
Dr. Ghada El-Hajj Fuleihan-Lebanon, Dr Akira Itabashi-Japan,
Dr M F Holic-USA, Dr Subhash Kukreja-USA, Dr D Sudhaker Rao-USA
and Dr Daniel Thiebaud from Australia. Dr Manoj Chadha-Mumbai,
Dr Ravinder Goswami-Delhi, Dr Sushil Gupta- Lucknow, Dr. Urvashi
Jha-Delhi, Dr Raman Marwaha-Delhi, Dr Ambrish Mithal-Delhi,
Dr Uma Ravishankar-Delhi, Dr Nikhil Tandon-Delhi and Dr Usha
Sriram from Chennai.
The scientific program was tailor made with
the topics like bone remodeling in health & disease, vitamin
D status in Indians, treatment of osteoporosis, SERMS and
calcitonin, bisphosphonates – recent advances and practical
issues in bone densitometry. |
Dr Ambrish
Mithal, President of ISBMR, welcomed the delegates and started
the conference with opening remarks on the objectives of The
Indian Society for Bone and Mineral Research and talked about
the spreading awareness of osteoporosis through physician
education and general public. Then he invited Mrs. Wilson
who is 78years old and suffering from osteoporosis for the
last 20 years to share her experiences & views with the
audience. |
|
|
|
| |
The morning
session was on “Pathophysiology of Osteoporosis”
and the first talk of this sessions was delivered by D Sudhaker
Rao-USA, on “Bone remodeling in health and disease:
new insights” saying that although skeletal homeostasis
and mineral homeostasis appear to be independent of each other,
they are in reality closely interrelated and interdependent.
Negative calcium balance will lead to bone loss and bone fractures,
and conversely, adequate calcium nutrition maintains |
bone strength
and integrity With the advent of bone densitometers, cellular
mechanisms responsible for bone loss have taken a back seat,
but bone density contributes only 30-35% or so for osteoporotic
fracture syndrome. Thorough understanding of bone biology,
skeletal homeostasis, and their intimate intricate relationships
to bone and mineral metabolism in general and mineral homeostasis
in particular, is essential for clinical practice of osteoporosis.
|
|
This was
followed by a talk on “Nutrition and osteoporosis”
by Dr Ghada El-Hajj Fuleihan from Lebanon who elaborated on
the rational and potential use and impact of nutrition on
bone health. She said that normal variations in dietary protein
may affect bone health; low protein intake seems to be associated
with bone loss, whereas high protein intake maintains BMD
in elderly persons. Protein intake promotes bone health through
effects on the IGF1 axis increasing BMD and a direct effect
on muscle, the latter also maintaining BMD and also reducing
falls and therefore fracture risk. |
A second session was
on “The Asian Scene” and first talk of this session
was delivered by Dr Akira Itabashi from Japan, who informed
the delegates about current status of Osteoporosis in Japan.
After a comprehensive review of literature he concluded his
talk by showing his trials and their results done in Japan
on the patient of Osteoporosis. Next talk was also on current
Indian scenario of Osteoporosis and detailed review of trials
done by Dr K M Prasanna, Bangalore. Next |
|
| talk was on “Vitamin D Status
in Indians” by Dr Raman Marwaha, Delhi, saying that high
prevalence of clinical and biochemical hypovitaminosis D and
low BMD in Indians especially from poorer sections of the society
suggests that nutrition plays an important role in causation
of hypovitaminosis D. |
| The afternoon session was on “Professor
MMS Ahuja Memorial Lecture” and the talk on “Vitamin
D for optimal Health” was delivered by Dr M F Holick,
Boston. |
|
|
The fourth
session was on “treatment of Osteoporosis” and
first talk of this session on “SERMS and calcitonin:
current status” was delivered by Dr Subhash Kukreja
from USA. This talk was followed by Dr D Sudhaker Rao on the
topic “ Bisphosphonates: resent advances”. He
explained in details about the Bisphosphonate therapy in various
metabolic bone disorders. He said that with the discovery
of bisphosphonates’ avidity to the skeleton, the therapeutic
horizon for managing osteoporosis has become much easier.
|
The first generation
bisphosphonates (etidronate and clodronate) were initially
developed for the treatment of Paget’s disease of bone
and were later found to be effective also in preventing age-related
bone loss and osteoporotic fractures. Only alendronate and
risedronate are currently approved for clinical use in osteoporosis.
Other related compounds, pamidronate, ibandronate, and zolidronate,
are also used in certain circumstances. Despite poor gastrointestinal
absorption, long biologic half-life and skeletal avidity make
them ideal drugs for osteoporosis management.
Dr Daniel Thiebaud from Sydney, delivered the next talk on
“New and emerging therapies” from Sydney. |
After evening
tea break, a session on “Practical Issues in Bone Densitometry”
was discussed between eminent moderators and panelists like
Dr Subhash Kukreja, Dr Uma Ravishanker, Dr Akira Itabashi,
Dr Ghada Fuleihan and Dr D Sudhaker Rao. |
|
 |
The symposium
was concluded by closing remarks of the faculty and vote of
thanks by Dr Nikhil Tandon. |
There was
an active participation of delegates through out the day in
the form of discussions on various problems and queries encountered
by them in day-to-day practice. |
|
| Poster
and oral presentation was also performed during the conference
by the participants from all over India and was published
in the conference proceeding book. |
|
|
| >>
PHYSICIAN AWARENESS CAMPAIGN LAUNCHED- MARCH 30, 2005 |
|
Office
Bearers 
about us
